Cost-effectiveness of TPMT Pharmacogenetics

NCT00521950 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

853

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases
Crohn Disease
Ulcerative Colitis

Interventions

GENETIC: TPMT genotyping; Drug: azathioprine or 6-mercaptopurine
DRUG: azathioprine (AZA) or 6-mercaptopurine (6-MP)

Sponsor

ZonMw: The Netherlands Organisation for Health Research and Development

Collaborators

[object Object]